Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-23

FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for carvedilol (generic), indicating regulatory approval related to the ANDA submission. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)